Type-2 Diabetes is associated with one of the co-morbidities due to SARS-Coronavirus 2 (SARS-Cov2) infection. Clinical studies show out of control glucose levels in SARS-Cov2 infected patients with type-2 diabetes. There is no experimental evidence suggesting aberrant molecular pathway(s) that explains why SARS-Cov2 infected patients with type-2 diabetes have uncontrolled glucose homeostasis and are co-morbid. In this article, we have highlighted major proteins involved in SARS-Cov2 infection, like, ACE 2, proteases like, TMPRSS2, Furin and their connectivity to insulin signaling molecules like, PI3K, Akt, AMPK, MAPK, mTOR, those regulate glucose homeostasis and the possible outcome of that cross-talk. We also raised concerns about the effect of anti-SARS-Cov2 drugs on patients with type-2 diabetes with reference to insulin signaling and the outcome of their possible cross-talk. There are no studies to decipher the possibilities of these obvious cross-talks. The major objective of this article is to urge the scientific community to explore the possibility of determining whether derangement of insulin signaling could be one of the possible causes of the patients with type-2 diabetes being co-morbid due to SARS-Cov2 infection.
Skip Nav Destination
Review Article| March 05 2021
Type-2 diabetes, a co-morbidity in Covid-19: does insulin signaling matter?
- Views Icon Views
- Share Icon Share
Devanshi Mishra, Chinmoy Sankar Dey; Type-2 diabetes, a co-morbidity in Covid-19: does insulin signaling matter?. Biochem Soc Trans 30 April 2021; 49 (2): 987–995. doi: https://doi.org/10.1042/BST20201062
Download citation file:
Don't already have an account? Register
Get Access To This Article
Buy This Article